Clinical Trial Update: SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update describes a Phase 2 study testing regorafenib in combination with nivolumab for osteosarcoma, including pediatric cases. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• OPDIVO (nivolumab)
• Stivarga (regorafenib)

Snippet

Sponsor: Sarcoma Alliance for Research through Collaboration | Conditions: Osteosarcoma, Osteosarcoma in Children | Phase 2 | Status: ACTIVE_NOT_RECRUITING